# Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients

> **NCT04346589** · NA · TERMINATED · sponsor: **A.O. Ospedale Papa Giovanni XXIII** · enrollment: 9 (actual)

## Conditions studied

- Pneumonia, Ventilator-Associated
- Coronavirus Infection

## Interventions

- **BIOLOGICAL:** Anti-coronavirus antibodies (immunoglobulins)obtained with DFPP from convalescent patients

## Key facts

- **NCT ID:** NCT04346589
- **Lead sponsor:** A.O. Ospedale Papa Giovanni XXIII
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-04-15
- **Primary completion:** 2021-02-17
- **Final completion:** 2022-10-27
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** The study was closed prematurely because the hyperimmune plasma have expired
- **Last updated:** 2023-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04346589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04346589, "Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT04346589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*